title: Fibrin gel structure obtained with a FVIIa analogue with enhanced FX-activating potential in haemophilia.
authors.forename: Shu
authors.initials: S
authors.lastname: He
authors.forename: Mirella
authors.initials: M
authors.lastname: Ezban
authors.forename: Niklas
authors.initials: N
authors.lastname: Bark
authors.forename: Egon
authors.initials: E
authors.lastname: Persson
authors.forename: Ulla
authors.initials: U
authors.lastname: Hedner
mesh_terms: D015942:Factor VIIa / Q000235:genetics / Q000378:metabolism* / Q000627:therapeutic use; D005170:Factor X / Q000378:metabolism; D005337:Fibrin / Q000378:metabolism*; D005782:Gels; D006467:Hemophilia A / Q000188:drug therapy / Q000235:genetics / Q000628:therapy; D006487:Hemostasis; D006801:Humans; D066298:In Vitro Techniques; D011485:Protein Binding; D011994:Recombinant Proteins / Q000235:genetics / Q000378:metabolism* / Q000627:therapeutic use; D013917:Thrombin / Q000235:genetics / Q000378:metabolism*; D054457:Tissue Scaffolds
chemical_list: D005782:Gels; D011994:Recombinant Proteins; D005170:Factor X; D005337:Fibrin; D015942:Factor VIIa; D013917:Thrombin